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Abstract
BACKGROUND: Genetic variations in ABCB1 gene that encodes P-glycoprotein, the main transporter in the 
efflux of carbamazepine (CBZ) from the brain cells, can lead to pharmacodynamic and pharmacokinetic variability. 
Polymorphism of C3435T is widely known to cause protein overexpression that contributes to an increased risk of 
CBZ resistance. 
AIM: This study determined the allele frequency distribution of ABCB1 C3435T gene in healthy subjects of the 
Javanese population as a major ethnic group in Indonesia.
METHODS: This cross-sectional study involved 100 healthy volunteers who fulfilled the inclusion criteria. The 
genotype analysis to detect polymorphism in the targets employed the polymerase chain reaction-restriction 
fragment length polymorphism method with 5’-TGCTGGTCCTGAAGTTGATCTGTGAAC-3’ as the forward primer 
and 5’-ACATTAGGCAGTGACTCGATGAAGGCA-3’ as the reverse primer.
RESULTS: The frequency of subjects with C allele in ABCB1 C3435T gene reached 53%, higher than that with T 
allele.
CONCLUSION: This finding was nearly the same as that in studies of the populations in China, Turkey, and four 
countries in the South European continent. It is recommended to conduct further research on the correlation between 
C3435T polymorphism and CBZ dose variability to provide a comprehensive approach to epilepsy management in 
patients receiving CBZ.
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Introduction
Epilepsy is the most prevalent chronic 
neurological disorder that affects at least 50 million 
people globally. It is characterized by periodic and 
unexpected seizures [1]. The prevalence in developing 
countries is higher than in developed countries; for 
example, the prevalence of epilepsy in Indonesia 
ranges between 5 and 74 per 1000 people. The best 
therapy in the management of epilepsy hitherto is using 
antiepileptic drugs (AEDs) [2].
Carbamazepine (CBZ) is a tricyclic compound 
used as the first-line AED for focal seizures, secondary 
generalized seizures, and tonic-clonic seizures [2]. 
CBZ is not only effective but also relatively inexpensive, 
making it listed in the AED monotherapy choices of 
the National Formulary since 2013 and available up to 
primary health-care facilities [3]. However, in addition 
to the risk of allergic reactions, CBZ is an AED with a 
narrow therapeutic range and often causes variations 
in pharmacokinetics and clinical response. Such 
variations occur due to polymorphism in the protein-
encoding gene that plays a role in bioavailability and 
clinical response [4]. A number of pharmacogenetic 
studies of CBZ have been conducted to analyze genetic 
variants that strongly correlate with the variability of 
pharmacokinetics, clinical response, and adverse drug 
reactions (ADR). Regarding the polymorphism of HLA-
B*1502 allele with the hazardous side effect named 
Stevens-Johnson Syndrome [5], research has been 
performed by involving the Indonesian population, with 
a frequency of mutant variant of 11.6% [6].
In addition to ADR risk, therapy failure due to 
CBZ resistance becomes another serious issue. It is 
estimated that approximately 30–40% epileptic patients 
experience AED resistance that leads to uncontrolled 
seizures despite the use of CBZ within the therapeutic 
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dose range [7], [8]. Furthermore, the maintenance 
dose of epileptic patients in monotherapy reaches 
10-fold variety, indicating a wide interpatient variability 
of clinical response [9]. Among the contributing factors 
is the genetic polymorphism in the major CBZ efflux 
transporter named P-glycoprotein (P-gp) which is 
also expressed in the blood-brain barrier (BBB) [10]. 
Various studies have proved that the genetic variations 
in ABCB1 C3435T gene as a P-gp encoder lead to 
CBZ resistance. A number of studies involving epileptic 
patients in Chinese, Japanese, and Caucasian 
populations found a positive correlation between such 
polymorphism and CBZ resistance or variations in CBZ 
plasma concentration [11], [12], [13]. Therefore, this 
study aims to determine the allele frequency distribution 
of ABCB1 C3435T gene among the Javanese 
population, the largest ethnic group in Indonesia.
Pharmacogenetic understanding and studies 
of epilepsy therapy can provide important basic 
information for the development and implementation 
of genetic screening in making a decision on epilepsy 
therapy as well as become the basis for patient 
individualized medicine. This study is a section of 
prospective research on AED pharmacogenetics 
among the Indonesian population with epilepsy. 
Analysis of genetic variants in the target P-gp encoding 
gene is important to provide information on the genetic 
variation profile among the Indonesian population of 
which implications for individual therapeutic dose and 
clinical response to CBZ use can be further examined.
Methods
Research subjects
The DNA was extracted from 3 ml blood of 
100 healthy respondents aged 18–23 years. The 
category of respondents was those from Javanese 
ethnic group identified based on their three previous 
generations. This study has obtained ethical clearance 
from the Ethics Committee of the Faculty of Medicine 
of Universitas Islam Indonesia with the protocol No. 35/
Ka.Kom.Et/70/KE/XII.
Genotyping
Genotyping of ABCB1 C3435T was conducted 
through the polymerase chain reaction (PCR) method 
using 5’-TGC TGG TCC TGA AGT TGA TCT GTG 
AAC-3’ as the forward primer and 5’-ACA TTA GGC 
AGT GAC TCG ATG AAG GCA-3’ as the reverse primer 
followed by restriction fragment length polymorphism. 
PCR conditions for amplification included initial 
denaturation at 95°C for 2 min, 35 denaturation cycles 
at the same temperature for 30 s, annealing at 55°C 
for 30 s, extension at 72°C for 30 s, and final extension 
at 72°C for 5 min. The amplification products were 
visualized using agarose gel electrophoresis with 1.5% 
agarose concentration at 100 volts for 30 min. The PCR 
products (248 bp) were digested using MboI enzyme 
that identified and cut |GATC sequence in the amplicon. 
The digestion of amplification products yielded 16 bp, 
60 bp, and 172 bp fragments of CC genotype, 16 bp, 
60 bp, 172 bp, and 232 bp of CT genotype, and 16 bp 
and 232 bp of TT genotype.
The genotype and allele frequencies 
were determined based on the data of previous 
studies [11], [12], [13], [14] that used Hardy–Weinberg’s 
law as follows [15], [16]:
Genotype frequencies 
A givennumber of allelesin
thepopulation
=
Totalnumber of allelesin
thepopulation
Meanwhile, the allele frequencies were 
determined using the following formula:
f C
Number of CCIndividuals
Number of CTIndividuals 
  

2
2
( )
( TotalNumber of Individuals)
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Number of TTIndividuals
Number of CTIndividuals  
  2
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( TotalNumber of Individuals)
f (C): C allele frequency
f (T): T allele frequency
Results and Discussion
A total of 100 healthy respondents of 
Javanese-Indonesian descent participated in the 
ABCB1 C3435T gene genotyping with the same 
numbers of male and female respondents. The research 
subject characteristics are described in Table 1.
Table 1: Characteristics of the subjects in ABCB1 C3435T 
genotyping
Patient characteristic Male (50) Female (50)
Average age (years) 21.3 ± 1.2 21.1 ± 1.4
Average BMI (kg/m2) 22.7 ± 4.1 21.5 ± 3.4
Types of ABCB1 C3435T genotype
CC 14 10
CT 29 29
TT 7 11
Types of ABCB1 C3435T allele
C 57 49
T 43 51
BMI: Body mass index.
This study found that the frequencies of 
genotypic variation of both male and female respondents 
were insignificantly different. Although it is acknowledged 
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that gender and genetic variation frequencies are not 
correlated, P-gp expression and function indicate 
gender variations at the molecular level [17]. Therefore, 
in a pharmacogenomic study targeting polymorphism 
in ABCB1 genes that encode P-gp protein, in addition 
to employing a prospective technique and adequate 
sample size [18], taking comorbidity factors into account, 
and using other drugs of P-gp inducer or inhibitor [19], 
and it is necessary to involve equal numbers of male 
and female patients to provide more accurate data 
analysis and results. Men and women have differences 
not only in P-gp expression and function but also in CBZ 
clearance, with even a significant difference level, in an 
infusion therapy [20].
Overall, the findings showed that the frequencies 
of CC, CT, and TT genetic variation in ABCB1 C3435T 
(rs1045642) were 24%, 58%, and 18%, respectively. 
Research with the same polymorphism targets as this 
study has been widely performed by involving a variety 
of populations and various races (Table 2.)
The electrophoretic display of enzyme 
digestion for the detection of target polymorphism in 
this study is shown in Figure 1.
Figure 1: Electrophoretic display of genotypic variations in the target 
SNPs. Lane M = marker of 50 bp; lane C = negative control; lane 
U = undigested; lane 1 and 2= CC homozygote/wild-type (172 bp and 
59 bp); lane 3 and 4= CT heterozygote (231 bp, 172 bp, and 59 bp); 
lane 5 and 6= TT homozygote (231 bp). SNPs: Single nucleotide 
polymorphisms
Numerous studies (Table 2) have linked 
genetic variations in P-gp encoding gene ABCB1 to 
mRNA stability variations [10], the risk of epilepsy, 
CBZ resistance, and therapeutic dose requirements. 
A study involving 738 subjects in South India showed 
that ABCB1 C3435T increased the risk of mesial 
temporal lobe epilepsy with hippocampal sclerosis [31]. 
In addition, a study of 84 Chinese epileptic patients who 
received CBZ monotherapy and 210 Chinese patients 
who received CBZ for at least 1 month found that 
ABCB1 3435-TT had a lower CBZ plasma concentration, 
and the ABCB1 3435CC group showed higher CDRCBZ 
(concentration: Dose ratio, i.e., the ratio of measured 
CBZ concentration to the daily maintenance dose 
in mg/kgBW) than the 3435CT type [13], [21]. Other 
studies of 315 epileptic patients at the National Hospital 
for Neurology and Neurosurgery in London as well as 
210 Japanese patients with epilepsy who were given 
CBZ for more than 2 years indicated different risks of 
CBZ resistance. The first study found that patients with 
CC genotype had a higher drug resistance compared 
to the group of TT genotype with 2.66 odds ratio (OR) 
and 1.32–5.38 confidence interval (CI) while the second 
study revealed that the TT genotype group was more 
prone to CBZ resistance instead (OR: 3.64, CI: 1.16–
11.39) [11], [12]. Contradictory results were shown 
by two studies, each of which involved 97 epileptic 
patients with CBZ monotherapy and 174 healthy 
volunteers and 34 patients and 81 healthy subjects, 
in which no correlation was found between ABCB1 
C3435T and either CBZ resistance or clinical response 
to AED [14], [29]. These varied results of studies 
that involved different ethnic groups or races should 
consequently consider the study of ABCB1 haplotype 
or diplotype that represents the functional unit of the 
gene [11]. Meanwhile, a systematic review and meta-
analysis of 13 studies involving a total of 454 patients 
with AED-resistant epilepsy and 282 response-to-AEDs 
indicated that TT genotype of ABCB1 C3435T played an 
important role in the incidence of refractory epilepsy [49].
The ATP-binding cassette transporter is 
widely known as the largest group of transmembrane 
transporters expressed in various tissue barriers 
including in the brain capillaries that construct the 
BBB, localized to the endothelial layer which can limit 
the entry of lipophilic drugs into the brain and express 
substances, such as β-amyloid, from neuroparenchyma. 
P-gp pushes xenobiotics from the intracellular part back 
to the capillary lumen, thus maintaining BBB integrity 
and reducing drug accumulation in the cerebral region. 
Since P-gp transporter is highly expressed in BBB, the 
polymorphism in ABCB1 gene as a P-gp encoder that 
influences the level of expression and function can 
directly affect the brain uptake as well as extrusion of 
AEDs, including CBZ. P-gp overexpression has been 
proven to play an important role in a pharmacoresistant 
incidence in epilepsy through decreased drug 
concentrations in the brain even though with a plasma 
therapeutic concentration [53].
Since P-gp is extensively expressed not only 
in BBB but also in various body tissues including in 
small intestine and large intestine, adrenal glands, liver, 
kidney, placenta, and capillary endothelial cells of testes, 
P-gp also plays a role in the absorption, distribution, and 
excretion of numerous drugs as its substrates, and its 
function can be influenced by the presence of inhibitor 
drugs. A number of studies have also found the influence of 
the target polymorphism in this study on pharmacokinetic 
variations, clinical response, and risk factors of cancer. 
C3435T polymorphism has also been proven to cause 
variations in the concentrations, dose requirements, 
and clinical response of the drugs that function in the 
central nervous system, such as phenobarbital, opioids, 
and aripiprazole [22], [36], [44]. Similarly, some studies 
found a significant influence of such polymorphism on 
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Population/ethnicity Sample size Genotype frequencies n (%) Findings References
CC CT TT
Original article
Javanese, Indonesian 100 24 (24.00) 58 (58.00) 18 (18.00) The mutant allele frequency of ABCB1 C3435T (47%) was lower 
than that of C allele
The present study
Chinese 84 30 (35.71) 39 (46.43) 15 (17.86) T allele was found at 41.1%. This allele correlated with the 
decreased plasma concentration of CBZ in Chinese patients with 
epilepsy
Meng et al. (2011) [13]
Turkish 97 29 (29.90) 55 (56.70) 13 (13.40) T allele frequency reached 41.8%. There was no significant 
correlation between MDR1 (C3435T) polymorphism and CBZ 
resistance among patients with epilepsy in Turkey
Ozgon et al. (2008) [14]
Japanese 210 70 (33.33) 92 (43.81) 48 (22.86) The mutant allele frequency of C3435T (44.8%) was lower compared 
to that of C allele. Epileptic patients with T allele and mutant TT 
variant genotype were more likely to experience CBZ resistance
Seo et al. (2006) [11]
Caucasian 315 73 (23.17) 169 (53.66) 73 (23.17) The frequency of T allele was identical with that of C allele in 
ABCB1 C3435T. If compared to patients with antiepileptic drug 
response, those with antiepileptic drug resistance had CC 
genotype in ABCB1 3435 as opposed to TT genotype
Siddiqui et al. (2003) [12]
Chinese 210 68 (32.38) 112 (53.33) 30 (14.29) T allele frequency was 41.0%. The study found that ABCB1 
c.3435C>T was significantly associated with the ratio of CBZ 
concentration to dose from CBZ and its primary metabolites in 
Chinese patients with epilepsy
Zhu et al. (2014) [21]
Chinese 112 45 (40.18) 49 (43.75) 18 (16.07) The mutant allele frequency of C3435T (37.9%) was lower than 
that of C allele. If cancer patients with TT genotype in ABCB1 
suffered pain, they required a higher dose of opioid compared to 
those with CC/CT type
Gong et al. (2013) [22]
Han Chinese 292 103 (35.28) 151 (51.71) 38 (13.01) T allele frequency was found at 38.9%. The ABCB1 rs1045642 
gene did not correlate with the therapeutic response of 
antidepressants (both selective serotonin reuptake inhibitors and 
serotonin-norepinephrine reuptake inhibitors) in Han Chinese 
patients with depression
Shan et al. (2019) [23]
Han Chinese 185 74 (40.00) 82 (44.32) 29 (15.68) T allele was 37.8%. Genotypic variation in rs1045642 did not 
influence the efficacy of etanercept in Han Chinese patients with 
ankylosing spondylitis
Yan et al. (2017) [24]
Han Chinese 236 58 (24.58) 47 (19.91) 131 (55.51) Different from the finding of this study, the mutant allele frequency 
of C3435T (65.5%) was higher than that of C allele. There was 
no significant difference in the dose of sufentanil for Han Chinese 
patients who suffered pain due to lung cancer
Zhao et al. (2019) [25]
Taiwanese 112 29 (25.89) 52 (46.43) 31 (27.68) T allele was found at 50.9%. Both the baseline score of Hamilton 
Depression Rating Scale and that of week 6 in antidepressant 
therapy were insignificantly different among the ABCB1 C3435T 
genotypic variance of Taiwanese patients with major depressive 
disorder
Chang et al. (2015) [26]
Japanese 154 (healthy subjects) 55 (35.72) 73 (47.40) 26 (16.88) The mutant allele frequency of C3435T was higher than that of 
C allele. No significant difference was found in the estimation of 
MDR1 haplotype frequency between Japanese healthy subjects 
(n=154) and patients with CRC as well as ESCC
Komoto et al. (2006) [27]
48 (patients with CRC) 14 (29.17) 28 (58.33) 6 (12.50)
47 (patients with 
ESCC)
11 (23.40) 28 (59.58) 8 (17.02)
Turkish 54 19 (35.19) 22 (40.74) 13 (24.07) T allele was found at 44.4%. The study found that the 
distributions of CC genotype and C allele in ABCB1 C3435T 
were significantly different between Turkish patients with major 
depressive disorder and healthy subjects (n=70). However, 
ABCB1 C3435T polymorphism did not influence the clinical 
response to citalopram
Ozbey et al. (2014) [28]
Iranian 115 (34 patients, 81 
healthy subjects)
24 (20.87) 58 (50.43) 33 (28.70) Contrary to our findings, the mutant allele frequency of C3435T 
(53.9%) was higher than that of C allele. The haplotype frequency 
estimation (including ABCB1 C3435T) did not indicate any 
significant difference between patients and the control group
Hosseini et al. (2018) [29]
Egyptian 220 (120 patients, 110 
healthy subjects as 
control group)
26 (11.82) 141 (64.09) 53 (24.09) T allele frequency was at 56.1%. The CT genotype in MDR1 gene 
C3435T correlated with the poor clinical outcomes in Egyptian 
pediatric patients with acute lymphoblastic leukemia
Talaat et al. (2018) [30]
South Indian 460 patients 24 (5.22) 245 (53.26) 191 (41.52) Different from our findings, the mutant allele frequency of C3435T 
(68.2%) was higher than that of C allele. This cohort study found 
that the variants in ABCB1 (including C3435T) did not correlate 
with antiepileptic drug resistance. However, ABCB1 C3435T 
polymorphism was associated with the risk of developing epilepsy 
in patients with mesial temporal lobe epilepsy with hippocampal 
sclerosis
Balan et al. (2014) [31]
Roman and 
Hungarian 
465; 503 healthy 
subjects
Roman 124 
(26.67)
Hungarian 
112 (22.27)
Roman 234 
(50.32)
Hungarian 
252 (50.10)
Roman 107 
(23.01)
Hungarian 139 
(27.63)
There was a significant difference in the T allele frequency of 
MDR1 between Roman population (48.2%) and Hungarian 
people (52.7%). The T allele frequency in our study was found to 
be comparable with that of Roman population
Sipeky et al. (2011) [32]
Polish 171 (71 patients, 100 
healthy subjects)
37 (21.64) 76 (44.44) 58 (33.92) T allele distribution was at 56.1%. 1236T-2677G-3435T haplotype 
could provide a protective effect against bullous pemphigoid
Rychlik-Sych et al. 
(2018) [33]
Polish 90 15 (16.67) 43 (47.78) 32 (35.55) T allele distribution (59.4%) was higher than that of C allele. 
C3435T polymorphism in ABCB1 gene strongly correlated with 
predisposition to depression, severity of depression symptoms, 
and effectiveness of antidepressants
Jeleń et al. (2015) [34]
Romanian 74 14 (18.92) 37 (50.00) 23 (31.08) T allele frequency was 56.1%. ABCB1 C3435T polymorphism 
did not influence the plasma concentration of valproate or dose 
adjustment with reference to valproate concentration among 
Romanian patients with epilepsy
Sabin et al. (2016) [35]
Croatian 60 16 (26.67) 31 (51.66) 13 (21.67) Similar to our finding, this study also found a lower T allele 
frequency (47.5%) as opposed to that of C allele. C3435T 
polymorphisms in ABCB1 gene influenced the concentration ratio 
of phenobarbital in serum/cerebrospinal fluid among Croatian 
patients with idiopathic primary generalized epilepsy who 
received phenobarbital monotherapy
Basic et al. (2008) [36]
Table 2: Genotype frequencies of ABCB1 C3435T in different ethnic populations
(Contd...)
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the pharmacokinetics of antiviral atazanavir and the 
clinical outcomes of artemether-lumefantrine antimalarial 
regimen [37], [45] as well as the chemotherapy clinical 
outcomes in pediatric patients with leukemia [30], [39]. 
Furthermore, C3435T rs1045642 polymorphism has 
even been proven to correlate significantly with 
amlodipine efficacy and safety, patients’ blood pressure 
after kidney transplantation, and the safety of dabigatran 
as a thrombin inhibitor [40], [42], [43]. Not only associated 
with pharmacogenomics because of their function 
as part of cellular defense mechanism, but C3435T 
polymorphism also has a significant clinical correlation as 
a predisposition to depressive disorders [28], [34], [38]. 
A similar finding was also found in a study of haplotype 
involving such polymorphism with the risk of colorectal 
and esophageal cancer and in a systematic review and 
meta-analysis regarding the genetic susceptibility to 
multiple myeloma [27], [41].
These relatively high frequencies of C3435T 
mutant allele among the Javanese-Indonesian 
population require further studies. This is in accordance 
with the lacking involvement of the Indonesian population 
in new drug development for a drug selection approach, 
availability of more appropriate therapeutic doses, and 
health promotion strategies to prevent cancer among 
vulnerable subject groups.
Conclusion
The findings in the study of ABCB1 rs1045642 
C>T allele frequencies among healthy volunteers of 
Javanese-Indonesian ethnic group become a novelty 
Population/ethnicity Sample size Genotype frequencies n (%) Findings References
CC CT TT
Original article
Spanish 74 21 (28.38) 33 (44.59) 20 (27.03) T allele (49.3%) was found to be less than C allele in ABCB1 
C3435T. In addition to the risk of developing hyperbilirubinemia, 
the plasma concentration of atazanavir was significantly higher in 
HIV-infected patients with CC genotype compared to those with 
CT or TT variants
Nóvoa et al. (2006) [37]
Portuguese 160 56 (35.00) 73 (45.62) 31 (19.38) T allele in ABCB1 C3435T was found at 42.2%. This allele 
provided protection against major depression in male subjects
Santos et al. (2013) [38]
937 260 (27.75) 482 (51.44) 195 (20.81) T allele (46.5%) was lower than C allele in ABCB1 C3435T. 
Patients with minor T allele in ABCB1 rs1045642 achieved 
better clinical outcomes as opposed to the CC genotype group 
undergoing gemtuzumab ozogamicin (GO) therapy and risk 
of relapse. Consistent results were also obtained when the 
genotype group was compared by GO and No-GO arms
Children’s Oncology 
Group AAML0531 Trial
Rafiee et al. (2019) [39]
Caucasian 40 15 (37.50) 18 (45.00) 7 (17.50) T allele distribution was found at 40.0%. Polymorphism of 
rs1045642 in ABCB1 gene significantly correlated with increased 
blood pressure in 1 year after patients had a kidney transplant
Bouatou et al. (2018) [40]
Caucasian
4 case-control studies
395 patients dan 418 
healthy subjects as 
control group
207 (25.46) 403 (49.57) 203 (24.97) T allele in ABCB1 C3435T was found at 49.8%. MDR1 C>T 
polymorphism was not associated with the risk of multiple 
myeloma
Razi et al. (2018) [41]
Caucasian 100 17 (17) 53 (53) 30 (30) T allele (56.5%) was found higher compared to C allele in ABCB1 
C3435T. The highest antihypertensive effect of amlodipine with 
minimum incidence of reactions was found in the Caucasian 
patient group with Stage I-II hypertension and TT genotype
Sychev et al. (2018) [42]
Russian 60 15 (25) 29 (48.33) 16 (26.67) T allele distribution in ABCB1 C3435T was 50.8%. Polymorphism 
of rs1045642 in ABCB1 gene made a major contribution to the 
safety of dabigatran in patients undergoing knee surgery
Sychev et al. (2018) [43]
Japanese 233 73 (31.33) 160 (68.67) Hattori et al. (2018) [44]
Angolan 101 77 (76.24) 16 (15.84) 8 (7.92) T allele distribution was at 15.8%. ABCB1 c.3435C>T drug 
transporter influenced the clinical outcomes of artemether-
lumefantrine in malaria patients without complications
Kiaco et al. (2017) [45]
Polish 196 46 (23.47) 83 (42.35) 67 (34.18) T allele (55.4%) was higher than C allele in ABCB1 C3435T. 
ABCB1 C3435T polymorphism was not a major factor in 
susceptibility to peptic ulcer but a risk factor in developing 
Helicobacter pylori infection in male patients
Sałagacka et al. 
(2011) [46] 
Spanish 473 138 (29.18) 243 (51.37) 92 (19.45) Similar to our study, this research also found T allele distribution 
(45.1%) that was lower than that of C allele. ABCB1 C3435T 
polymorphism influenced the elimination of several antipsychotics 
and antidepressants
Saiz Rodríguez et al. 
(2018) [47]
Systematic review/meta-analysis
Category Sample Findings References
Meta-analysis in studies of Caucasian and Asian 8604 ABCB1 C3435T polymorphism was a genetic marker for 
antiepileptic drug resistance associated with Caucasian 
population but not among Asian people
Li et al. (2015) [48]
Systematic review and meta-analysis of 13 studies 736 TT genotype in ABCB1 C3435T played a role in refractory 
epilepsy
Chouchi et al. (2017) [49]
Moroccan case-control study and meta-analysis Various populations in the 
meta-analysis; 60 patients 
and 68 healthy women in the 
case-control study
The implication of C3435T variant on the risk of breast cancer 
was ethnicity-dependent. The case-control study found no 
evidence that such polymorphism played an important role in 
susceptibility to breast cancer
Tazzite et al. (2016) [50]
Meta-analysis of 17 studies 2431 cases and 3028 
controls from various 
countries and ethnic groups
C3435T polymorphism in ABCB1 gene was associated with an 
increased risk of leukemia
Ma et al. (2015) [51]
Meta-analysis of 12 studies Varied ethnic groups C3435T polymorphism in ABCB1 gene could become a risk 
factor in major adverse cardiovascular events among patients 
who received clopidogrel, and TT homozygote had a lower 
hemorrhage risk than CC homozygote
Su et al. (2012) [52]
CBZ: Carbamazepine, CRC: Colorectal cancer, ESCC: Esophageal squamous cell carcinoma, MDR: Multidrug resistance.
Table 2: (Continued)
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in the preliminary study of CBZ pharmacogenetics 
study that has never been conducted. The results 
indicate that the frequency of subjects with T allele in 
ABCB1 C3435T gene was lower than that with C allele, 
reaching 47%. Further research is recommended to 
analyze the correlation between such polymorphism 
and their implications for pharmacokinetic variability as 
well as CBZ resistance.
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